Stay updated on Cemiplimab Study in Cervical Cancer Adults Clinical Trial

Sign up to get notified when there's something new on the Cemiplimab Study in Cervical Cancer Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cemiplimab Study in Cervical Cancer Adults Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:27:55.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a shift in the comparison of overall survival (OS) for patients with recurrent or metastatic cervical cancer treated with either cemiplimab or investigator's choice (IC) chemotherapy in a Phase 3 clinical trial.
    Difference
    0.1%
    Check dated 2024-06-06T14:39:24.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to provide a detailed explanation of eligibility criteria, including examples such as general health condition or prior treatments. This change offers more context on what researchers look for in potential participants for clinical trials.
    Difference
    16%
    Check dated 2024-05-22T20:55:56.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:14:59.000Z thumbnail image

Stay in the know with updates to Cemiplimab Study in Cervical Cancer Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cemiplimab Study in Cervical Cancer Adults Clinical Trial page.